Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
Go back to Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab| Abbott Laboratories (NYSE: ABT) | Delayed: 102.61 +0.38 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.23 | 52 Week High | $46.38 | |||
| Open | $101.83 | 52 Week Low | $36.00 | |||
| Day High | $103.19 | P/E | 68.41 | |||
| Day Low | $101.50 | EPS | $1.50 | |||
| Volume | 27,075,235 | |||||
